We are thrilled to announce that Eversyn is proud to support the organization of GlycoBioTec2025! As a leading force in advancing glycobiotech innovations, we are excited to contribute to this event that promises to drive the future of glycoscience and its application.

The project aims to delineate the mechanisms and effects of Human Milk Oligosaccharides (HMOs) on the immune system and the intestinal epithelium in relevance to non- communicable diseases, while at the same time, investigate methods for large scale production for more complex, functional HMOs.

After being voted by Plug and Play's Food & Beverage partners, eversyn has been accepted into Plug and Play’s Accelerator - Food & Beverage - Batch 15! Over the next three months, we're set to immerse ourselves in exclusive workshops, personalized 1:1 #mentor sessions, and access to private #dealflows, all thanks to the expansive network provided by Plug and Play.

Global Investor Forum offers up to 30 start-up companies in the field of biotech, medtech and AI & digital health to present themselves to leading investors and other potential partners.

Rachel who manages the business development of eversyn will present the future of cell-free biosynthesis in a three-minute pitch to potential partners and investors.

Alberto who is spearheading the bioprocess development of eversyn will present at the eighteenth annual BIO-Europe Spring®, March 18-20, 2024, in Barcelona, Spain.

We are pleased to join the 17th Annual European Life Sciences CEO Forum (#Sachs_ELSF) that will take place on the 28th - 29th February 2024 back at the Hilton Zurich Airport Hotel. The event will be part of the Sachs Spring Life Sciences Week, which will also incorporate the 5th Annual European HealthTech CEO Forum.

We cordially invite you to join us at our exclusive pitching session, where we'll unveil how precision biotransformation can become a game changer in nutrition and biopharma production. Our founder - Dr. Thomas Rexer is eager to share our vision and engage in thought-provoking discussions with you.

The startup week at Martin Luther University Halle-Wittenberg (MLU ) could not have kicked off with more momentum. On the very first day, the university's transfer and start-up service transformed the Volkspark in Halle into a stage for the Startup FOCUS Pitch & Connect event. Support was provided by the International Startup Campus and Univations GmbH.

The ISC Vietnam Team, together with partners, mentors, experts, and friends, provided 6 German startups with an information package about Vietnam as a target market, as well as crucial business contacts with potential cooperation partners, such as distributors, customers, suppliers, and research partners.

Rachel will present the future of precision biotransformation in a five-minute pitch to potential investors. Together with Sebatian, she will be also available at the eversyn booth to answer all your questions about eversyn’s unique technology for nutrition and biopharma 🚀

🚀 Karim is set to unveil our Glycoengineering Toolbox, maximizing control over glycosylation for your biologics.

Rachel who manages the business development of eversyn will present the future of precision biotransformation in a three-minute pitch to potential investors. Rachel & Volker (eversyn's CEO) will be also available at the eversyn booth to answer all your questions about eversyn’s unique technology for nutrition and biopharma 🚀

eversyn today announced the appointment of Dr. Ing. Volker Landschütze as its Chief Executive Officer, following an intensive talent search supported by Max Planck Innovation. For the first time since founded, eversyn has its first CEO.

This FASEB Science Research Conference (SRC) will explore the novel findings on human milk composition and bioactive function. Participants for this meeting will be principal scientists from various sectors who are interested in the breast milk area of research.

For preparing a spin-off, engaging in fundraising, creating a vision and strategy for growing, foundation and product positioning.

Our whole team will be present in person at the GlycoBioTec 2023. We are looking forward to meeting you at our booth in the exhibition hall. Moreover, we will present our technology with a talk at the conference. Stay tuned for more information.

We are delighted to announce that our team is supported by an EXIST research transfer grant over 0.9 Mio € from the Federal Ministry for Economics and Climate Action. eversyn will use the proprietary, cost-efficient and highly scalable technology for the synthesis of nucleotide sugars and valuable oligosaccharides.